In particular, hepatic inflammation and fibrosis were significantly inhibited in PN-knockout mice, mainly through a transforming growth factor (TGF)-β1 and TGF-β2 dependent mechanism, revealing a potential role of PN in NASH [9,15]. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.